Complexity made simple in diffuse large B-cell lymphoma.
editorial · Level V
Where this comes from
- Record sourced from PubMed, PMID 19706818.
- Also identified by DOI 10.1158/1078-0432.CCR-09-1444 and PMC identifier 2737086.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Diffuse large B cell lymphoma (DLBCL) is a heterogeneous disease and response to therapy is difficult to predict. An algorithm to sort DLBCL cases using a series of five immunohistochemical markers (GCET1, CD10, BCL6, MUM1, FOXP1) accurately predicts survival in patients treated with current chemotherapeutic regimens.
Medical subject headings
- B-Lymphocytes
- Lymphoma, Large B-Cell, Diffuse